News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
885,590 Results
Type
Article (88937)
Company Profile (555)
Press Release (796078)
Multimedia
Podcasts (244)
Webinars (36)
Section
Business (267065)
Career Advice (4164)
Deals (40026)
Drug Delivery (181)
Drug Development (91781)
Employer Resources (207)
FDA (18599)
Job Trends (17497)
News (398890)
Policy (40022)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (6)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3059)
Academic (2)
Accelerated approval (60)
ADA (49)
Adcomms (42)
Allergies (211)
Alliances (56991)
ALS (243)
Alzheimer's disease (2014)
Antibody-drug conjugate (ADC) (588)
Approvals (18992)
Artificial intelligence (917)
ASCO (345)
Autoimmune disease (384)
Automation (69)
Bankruptcy (409)
Best Places to Work (12635)
BIO (79)
BIOSECURE Act (23)
Biosimilars (261)
Biotechnology (336)
Bladder cancer (216)
Brain cancer (86)
Breast cancer (861)
Cancer (6800)
Cardiovascular disease (574)
Career advice (3601)
Career pathing (53)
CAR-T (395)
CDC (77)
Celiac Disease (3)
Cell therapy (1107)
Cervical cancer (58)
Clinical research (79381)
Collaboration (2469)
Commercialization (1)
Company closure (8)
Compensation (1588)
Complete response letters (111)
COVID-19 (3046)
CRISPR (130)
C-suite (1361)
Cystic fibrosis (170)
Data (8993)
Decentralized trials (3)
Denatured (93)
Depression (205)
Dermatology (105)
Diabetes (729)
Diagnostics (7650)
Digital health (73)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (461)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (333)
Earnings (102575)
Editorial (81)
Employer branding (25)
Employer resources (177)
Events (138990)
Executive appointments (1227)
FDA (22869)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (37)
Funding (2024)
Gene editing (283)
Generative AI (93)
Gene therapy (872)
GLP-1 (1299)
Government (5570)
Grass and pollen (8)
Guidances (426)
Healthcare (21274)
Hematology (198)
HIV (100)
Huntington's disease (71)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (119)
Immunology and inflammation (367)
Immuno-oncology (122)
Indications (225)
Infectious disease (3456)
Inflammatory bowel disease (246)
Inflation Reduction Act (17)
Influenza (156)
Intellectual property (333)
Interviews (822)
IPO (18014)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (24)
Labor market (126)
Layoffs (696)
Leadership (54)
Legal (10172)
Liver cancer (111)
Longevity (38)
Lung cancer (897)
Lymphoma (492)
Machine learning (70)
Management (68)
Manufacturing (1303)
Marketing (5)
MASH (231)
Medical affairs (1)
Medical device (15309)
Medtech (15501)
Mergers & acquisitions (23367)
Metabolic disorders (1879)
mRNA (281)
Multiple sclerosis (213)
NASH (24)
Neurodegenerative disease (535)
Neuropsychiatric disorders (132)
Neuroscience (3835)
Neurotech (2)
NextGen: Class of 2026 (7717)
Non-profit (5146)
Now hiring (84)
Obesity (892)
Opinion (381)
Ovarian cancer (252)
Pain (292)
Pancreatic cancer (375)
Parkinson's disease (431)
Partnered (42)
Patents (686)
Patient recruitment (826)
Peanut (72)
People (68202)
Pharmaceutical (81)
Pharmacy benefit managers (38)
Phase 1 (24526)
Phase 2 (34481)
Phase 3 (25928)
Pipeline (10363)
Policy (406)
Postmarket research (3561)
Preclinical (11006)
Press Release (72)
Prostate cancer (358)
Psychedelics (75)
Radiopharmaceuticals (381)
Rare diseases (1340)
Real estate (7463)
Recruiting (82)
Regulatory (30689)
Reports (77)
Research institute (2775)
Resumes & cover letters (654)
Rett syndrome (47)
RNA editing (31)
RSV (100)
Schizophrenia (199)
Series A (347)
Series B (251)
Service/supplier (15)
Sickle cell disease (133)
Special edition (33)
Spinal muscular atrophy (192)
Sponsored (55)
Startups (4378)
State (2)
Stomach cancer (21)
Supply chain (150)
Tariffs (104)
The Weekly (148)
Vaccines (1337)
Venture capital (143)
Weight loss (607)
Women's health (147)
Worklife (25)
Date
Today (49)
Last 7 days (438)
Last 30 days (2168)
Last 365 days (33245)
2026 (18215)
2025 (33215)
2024 (37864)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1297)
Alabama (103)
Alaska (7)
Arizona (410)
Arkansas (16)
Asia (52444)
Australia (9218)
California (14701)
Canada (4139)
China (1654)
Colorado (632)
Connecticut (649)
Delaware (452)
Europe (120942)
Florida (2216)
Georgia (478)
Hawaii (4)
Idaho (70)
Illinois (1290)
India (110)
Indiana (673)
Iowa (25)
Japan (624)
Kansas (144)
Kentucky (58)
Louisiana (64)
Maine (91)
Maryland (1767)
Massachusetts (10761)
Michigan (427)
Minnesota (818)
Mississippi (7)
Missouri (168)
Montana (37)
Nebraska (31)
Nevada (158)
New Hampshire (92)
New Jersey (3891)
New Mexico (35)
New York (3887)
North Carolina (1951)
North Dakota (11)
Northern California (7343)
Ohio (458)
Oklahoma (27)
Oregon (46)
Pennsylvania (2883)
Puerto Rico (33)
Rhode Island (53)
South America (1669)
South Carolina (91)
South Dakota (2)
Southern California (5797)
Tennessee (241)
Texas (2386)
United States (52522)
Utah (442)
Vermont (2)
Virginia (369)
Washington D.C. (88)
Washington State (1192)
West Virginia (4)
Wisconsin (159)
Wyoming (2)
There are 885,590 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Alzheimer’s disease
AAIC 2026: Tau-targeted Alzheimer’s treatments heat up while amyloid therapies persist
The lineup at the Alzheimer’s Association International Conference will provide critical insight into where the industry is headed with regard to targets being explored to vanquish the elusive neurodegenerative disease.
July 10, 2026
·
6 min read
·
Michael Gibney
Antibody-drug conjugates
GSK and Hansoh’s ADC clinches late-stage win, teeing up regulatory submission in China
GSK and Hansoh Pharmaceutical’s antibody-drug conjugate success validates their partnership, one of the many deals in which Big Pharma has tapped a China company for promising cancer candidates.
July 10, 2026
·
1 min read
·
Gabrielle Masson
Press Releases
SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma
July 10, 2026
·
5 min read
Press Releases
Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
July 10, 2026
·
4 min read
Press Releases
VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience
July 10, 2026
·
10 min read
Press Releases
NorthStrive Biosciences to Advance EL-22 Manufacturing Characterization with Quantitative FACS Analysis of Latent Myostatin Antigen Expression
July 10, 2026
·
6 min read
Cardiovascular disease
AstraZeneca, Ionis’ Wainua woes send waves across ATTR-CM space
The failure of AstraZeneca and Ionis’ Wainua in a late-stage study of ATTR-CM casts doubt on Alnylam’s next-generation candidate but is good news for others in the space, including BridgeBio and Intellia Therapeutics.
July 10, 2026
·
3 min read
·
Tristan Manalac
Huntington’s disease
Roche scraps 2 Huntington’s studies, handing Ionis more bad news
Roche’s decision to discontinue the Ionis-partnered trials came soon after the biotech sustained a late-stage failure in ATTR-CM.
July 10, 2026
·
2 min read
·
Tristan Manalac
Press Releases
BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission
July 10, 2026
·
5 min read
Press Releases
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - July 10, 2026
July 10, 2026
·
1 min read
1 of 88,559
Next
